RAMM Pharma Corp. RAMM

Company Overview

RAMM Pharma Corp. is a pharmaceutical and cannabis-focused company operating at the intersection of regulated cannabis, pharmaceutical manufacturing, and healthcare distribution. The company’s core activities involve the production, commercialization, and distribution of cannabis-derived products and pharmaceutical-grade formulations, primarily for medical and scientific markets. RAMM operates within the pharmaceutical, medical cannabis, and healthcare distribution industries, with a strategic emphasis on regulated international markets rather than adult-use retail.

The company’s primary revenue drivers have historically included the sale and distribution of pharmaceutical products through licensed channels and the development of cannabis-derived medicines. RAMM has positioned itself as an early entrant into Latin American medical cannabis markets, particularly Uruguay, leveraging local regulatory approvals and infrastructure. Founded in 2014 and originally focused on pharmaceutical imports and distribution, RAMM later expanded into cannabis cultivation and extraction following regulatory changes, evolving into a vertically integrated operator with both pharmaceutical and cannabis assets.